All News

A BRCA2-positive previvor shares her 20-year journey, offering empowering advice and community support for those navigating genetic mutation news.

Learn about nodular melanoma symptoms, diagnosis and treatments like immunotherapy to prepare for important conversations with your oncologist.

A retired teacher’s plans for "Act II" are derailed by a breast cancer diagnosis, bringing an onslaught of appointments and a double mastectomy.

CURE editor-in-chief Dr. Joshua Sabari explores how ctDNA liquid biopsies could transform breast cancer care while balancing costs and patient anxiety.

A CURE blogger shares the profound relief of learning her son tested negative for Lynch syndrome, ending a heavy generational cancer burden.

FDA approved Datroway for unresectable or metastatic triple-negative breast cancer not eligible for PD-1 or PD-L1 therapy with PFS, OS and response rates vs chemotherapy.

Study finds breast cancer patients with vitamin D deficiency are three times more likely to report moderate pain and receive more opioids after surgery

Colonoscopies can do more than detect colorectal cancer early — they can prevent it by removing precancerous polyps before cancer develops.

Survivor Erica Deligne discusses "going flat," the power of internal beauty and how fashion helps patients reclaim their autonomy.

ASCO 2026 will highlight biomarker-driven lung cancer care, targeted therapies, ADCs and phase 3 trials shaping precision oncology advances.

Breast cancer survivor Erica Deligne advocates for body autonomy and challenges the medical industry’s default toward breast reconstruction.

A lung and breast cancer survivor shares how genetic history, supporting her daughter and leading a support group helped her keep smiling.

Oncology nurse Tammy Zinn, an Extraordinary Healer finalist, expanded support through wish-granting programs, counseling and survivorship care for patients with cancer.

Oncology nurse Jill Winther was honored for decades of patient advocacy, education and compassionate support across cancer care settings.

Dr. Erica Mayer of Dana-Farber highlights new data on chemotherapy-free HER2+ treatment, ctDNA monitoring and oral SERDs at ESMO Breast 2026.

A testicular cancer survivor reflects on the importance of Mental Health Awareness Month, finding healing in nature, gratitude and creative renewal.

The FDA approved Enhertu for presurgical HER2+ breast cancer treatment. Dr. Shanu Modi discusses the "win-win" for patient efficacy and safety.

Zynyz plus chemotherapy improved overall survival for patients with advanced anal cancer in the phase 3 POD1UM-303/InterAACT-2 trial.

At ONS Congress 2026, Elianna Tobin shared how nurse navigator outreach helped patients feel more prepared before cancer appointments.

AI may improve symptom management, patient education and workflows in cancer care, but nurses remain essential.

Learn the risk factors, symptoms and screening options tied to colorectal cancer as cases continue rising among younger adults.

A survivor shares why advocating for a mammogram past age 75 led to a crucial second diagnosis and why family history means staying vigilant for life.

New research suggests biologic aging and neighborhood-related stress may affect how aerobic exercise influences cognition after breast cancer treatment.

Talking about what matters most with your nurses can improve your care and comfort during intensive treatments like stem cell transplants.

Patients receiving immunotherapy may develop lifelong endocrine adverse effects requiring insulin, hormone therapy and ongoing support.

A moving journey through breast cancer, discovering that vulnerability is courage and a diagnosis doesn't have to define your spirit or faith.

New research shows maintaining physical function and nutrition may help patients with advanced liver cancer stay on treatment longer and live longer.

The FDA approved Enhertu for certain patients with HER2-positive early-stage breast cancer before and after surgery based on DESTINY trial data.